Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations

Current dry powder formulations for inhalation deposit a large fraction of their emitted dose in the upper respiratory tract where they contribute to off-target adverse effects and variability in lung delivery. The purpose of the current study is to design a new formulation concept that more effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Danforth P., Tarara, Thomas E., Weers, Jeffry G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624185/
https://www.ncbi.nlm.nih.gov/pubmed/34834270
http://dx.doi.org/10.3390/pharmaceutics13111855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624185/
https://www.ncbi.nlm.nih.gov/pubmed/34834270
http://dx.doi.org/10.3390/pharmaceutics13111855

Ejemplares similares